Global Burden of Esophageal Cancer Remains Considerable
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 18, 2024 -- The burden of esophageal cancer (EC) remains substantial worldwide, with an upward trend seen in age-related EC burden, according to a study recently published in Cancer, Biology & Medicine.
Yi Teng, from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, and colleagues examined the global burden of EC and assessed temporal trends and factors influencing changes in the burden. Mortality and disability-adjusted life-year (DALY) rates for EC were sourced from 1990 to 2019 from the 2019 Global Burden of Diseases.
The researchers found that in 2022, an estimated 511,054 new cases of EC were diagnosed, with 445,391 deaths worldwide; about 75 percent of cases and deaths were in Asia. In 2019, in men, nearly 50 percent of global EC deaths and DALYs were attributable to tobacco use; in women, a high body mass index (BMI) accounted for 20 percent. From 1990 to 2019, declining trends were seen in EC deaths and DALYs attributable to almost all risk factors, while upward trends were seen for EC deaths and DALYs attributable to high BMI in men. There was an upward trend observed in age-related EC burden, driven by population growth and aging, which contributed to 307,400 EC deaths and 7.2 million DALYs.
"The burden of EC remains substantial and shows an upward trend worldwide, particularly in males," the authors write. "Effective measures to control tobacco use and obesity are critical for addressing the risk-attributable burden of EC."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk
MONDAY, March 3, 2025 -- Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4)...
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium-glucose co-transporter (SGLT)-1/2...
Psychosomatic Misdiagnosis Can Have Lasting Negative Impact on Patients
MONDAY, March. 3, 2025 -- Chronic diseases misdiagnosed as psychosomatic can lead to long-term damage to patients' physical and mental well-being, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.